BDBM532442 US11214548, Compound 711::{[(1aR,5aR)-2-(4-Oxy-pyrazin-2-yl)-1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carbonyl]-amino}-pyridin-2-yl-acetic acid methyl ester

SMILES COC(=O)c1cc(NC(=O)c2nn(c3[C@@H]4C[C@@H]4Cc23)-c2c[n+]([O-])ccn2)ccn1

InChI Key InChIKey=NAIOEPQQPTYTCK-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 532442   

TargetCannabinoid receptor 1(Human)
Arena Pharmaceuticals

US Patent
LigandPNGBDBM532442({[(1aR,5aR)-2-(4-Oxy-pyrazin-2-yl)-1a,2,5,5a-tetra...)
Affinity DataEC50:  28.1nMAssay Description:Table D: Radioligand binding assays for human CB2 receptors were performed using two different agonist radioligands, [3H]CP55,940 and [3H]WIN55,212-2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
US Patent